Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Medicinal Plant Images

    Medicinal Plant Images

    Web AdminBy Web AdminDecember 24, 2021Updated:January 5, 2022No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    I E Cock1,2,*

    1Environmental Futures Research Institute, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.

    2School of Natural Sciences, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    DOI: 10.5530/pc.2022.1.8

    Figure 1: Tasmannia lanceolata (Poir) A.C.Sm. (Family Winteraceae), commonly known as Tasmanian pepper or mountain pepper berry, is shrub which is endemic to the woodlands and cool temperate rainforests of Tasmania and the south-eastern region of the Australian mainland. The leaves, berries and bark of this plant have traditional uses as a food flavouring, and as a medicinal plant. Australian Aborigines used T. lanceolata as a therapeutic agent to treat stomach disorders and as an emetic, as well as general usage as a tonic.1 That study reported that T. lanceolata was used by Australian Aborigines for the treatment and cure of skin disorders, venereal diseases, colic, stomach ache and as a quinine substitute. Several of these traditional uses have been validated in recent publications. The antibacterial properties of T. lanceolata have been particularly well reported against a wide variety of bacterial species.2-6 Similarly, the related species Tasmannia stipatata7 and Pseudowintwera colorata (Raoul) Dandy8 have also been reported to inhibit the growth of multiple bacteria. T. lanceolata extracts have also been reported to inhibit the growth of the gastrointestinal protozoal parasite Giadria duodenalis.6,9 Similar extracts also inhibit the proliferation of several human cancer cell lines.6,10

    Figure 2: Australian Acacia spp. The genus Acacia (family Fabaceae) is a large genus of more than 1200 trees and shrubs which are widely distributed throughout the world, with more than 700 species indigenous to Australia. The Australian species had multiple medicinal uses by indigenous Australians, including being used to treat diarrhoea and hyperglycemia11 and as a general antiseptic agent12-15 Many Australian Acacia species have been reported to have amtimicrobial, molluskicidal, antihypertensive and platelet aggregatory activities.11 This photograph was taken at Griffith University, Australia in 2015 by Dr Ian Cock.

    Download PDF

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up